Bone Marrow TransplantationTransplantation, AutologousBone MarrowTransplantation, HomologousBone Marrow CellsBone Marrow PurgingWhole-Body IrradiationHematopoietic Stem Cell TransplantationGraft vs Host DiseaseCombined Modality TherapyCyclophosphamideTransplantation ConditioningLymphoma, Non-HodgkinCarmustineMelphalanLiver TransplantationBusulfanLeukemiaGraft SurvivalRemission InductionHematopoietic Stem CellsAntineoplastic Combined Chemotherapy ProtocolsBone and BonesRecurrenceEtoposideAnemia, AplasticLeukemia, Myeloid, AcuteTreatment OutcomeHodgkin DiseaseTransplantation ChimeraCytarabineBone Marrow DiseasesStem Cell TransplantationHematopoiesisTissue DonorsKidney TransplantationColony-Forming Units AssaySurvival AnalysisLeukemia, MyeloidPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation, IsogeneicMultiple MyelomaHistocompatibility TestingTime FactorsActuarial AnalysisHistocompatibilitySalvage TherapyVincristineDisease-Free SurvivalGranulocyte Colony-Stimulating FactorLymphomaSurvival RateImmunosuppressive AgentsFollow-Up StudiesHematologic NeoplasmsAcute DiseaseRetrospective StudiesHeart TransplantationGraft RejectionBone Marrow ExaminationImmunosuppressionMice, Inbred C57BLLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyelodysplastic SyndromesPodophyllotoxinRadiation ChimeraTransplantation ImmunologyHepatic Veno-Occlusive DiseaseLung TransplantationLeukocyte CountAntigens, CD34Hematopoietic Stem Cell MobilizationDrug EvaluationT-LymphocytesBone Marrow NeoplasmsPrognosisThiotepaCyclosporinePeripheral Blood Stem Cell TransplantationPrednisoneCell TransplantationHematologic DiseasesBlood Cell CountGraft vs Host ReactionAntibodies, MonoclonalLymphocyte DepletionBone RemodelingOrgan TransplantationCell SeparationLeukocyte TransfusionProspective StudiesHLA AntigensGranulocytesGraft vs Tumor EffectCell DifferentiationNeoplasm, ResidualPlatelet CountSevere Combined ImmunodeficiencyChimeraCells, Cultured